[HTML][HTML] Erlotinib versus gefitinib for brain metastases in Asian patients with exon 19 EGFR-mutant lung adenocarcinoma: a retrospective, multicenter study
Y Jiang, J Zhang, J Huang, B Xu, N Li, L Cao… - BMC Pulmonary …, 2018 - Springer
Background The purpose of this study was to compare clinical outcomes of Erlotinib versus
Gefitinib in the treatment of Asian patients with exon 19 EGFR-mutant lung adenocarcinoma …
Gefitinib in the treatment of Asian patients with exon 19 EGFR-mutant lung adenocarcinoma …
[HTML][HTML] Erlotinib versus gefitinib for brain metastases in Asian patients with exon 19 EGFR-mutant lung adenocarcinoma: a retrospective, multicenter study
Y Jiang, J Zhang, J Huang, B Xu… - BMC …, 2018 - bmcpulmmed.biomedcentral.com
The purpose of this study was to compare clinical outcomes of Erlotinib versus Gefitinib in
the treatment of Asian patients with exon 19 EGFR-mutant lung adenocarcinoma and newly …
the treatment of Asian patients with exon 19 EGFR-mutant lung adenocarcinoma and newly …
Erlotinib versus gefitinib for brain metastases in Asian patients with exon 19 EGFR-mutant lung adenocarcinoma: a retrospective, multicenter study
Y Jiang, J Zhang, J Huang, B Xu… - BMC pulmonary …, 2018 - pubmed.ncbi.nlm.nih.gov
Background The purpose of this study was to compare clinical outcomes of Erlotinib versus
Gefitinib in the treatment of Asian patients with exon 19 EGFR-mutant lung adenocarcinoma …
Gefitinib in the treatment of Asian patients with exon 19 EGFR-mutant lung adenocarcinoma …
[HTML][HTML] Erlotinib versus gefitinib for brain metastases in Asian patients with exon 19 EGFR-mutant lung adenocarcinoma: a retrospective, multicenter study
Y Jiang, J Zhang, J Huang, B Xu, N Li… - BMC Pulmonary …, 2018 - ncbi.nlm.nih.gov
Background The purpose of this study was to compare clinical outcomes of Erlotinib versus
Gefitinib in the treatment of Asian patients with exon 19 EGFR-mutant lung adenocarcinoma …
Gefitinib in the treatment of Asian patients with exon 19 EGFR-mutant lung adenocarcinoma …
Erlotinib versus gefitinib for brain metastases in Asian patients with exon 19 EGFR-mutant lung adenocarcinoma: a retrospective, multicenter study.
Y Jiang, J Zhang, J Huang, B Xu, N Li… - BMC Pulmonary …, 2018 - europepmc.org
Background The purpose of this study was to compare clinical outcomes of Erlotinib versus
Gefitinib in the treatment of Asian patients with exon 19 EGFR-mutant lung adenocarcinoma …
Gefitinib in the treatment of Asian patients with exon 19 EGFR-mutant lung adenocarcinoma …
Erlotinib versus gefitinib for brain metastases in Asian patients with exon 19 EGFR-mutant lung adenocarcinoma: a retrospective, multicenter study.
Y Jiang, J Zhang, J Huang, B Xu, N Li… - BMC Pulmonary …, 2018 - search.ebscohost.com
Abstract < bold> Background: </bold> The purpose of this study was to compare
clinical outcomes of Erlotinib versus Gefitinib in the treatment of Asian patients with exon 19 …
clinical outcomes of Erlotinib versus Gefitinib in the treatment of Asian patients with exon 19 …
[PDF][PDF] Erlotinib versus gefitinib for brain metastases in Asian patients with exon 19 EGFR-mutant lung adenocarcinoma: a retrospective, multicenter study
Y Jiang, J Zhang, J Huang, B Xu, N Li, L Cao… - 2018 - bmcpulmmed.biomedcentral.com
Background: The purpose of this study was to compare clinical outcomes of Erlotinib versus
Gefitinib in the treatment of Asian patients with exon 19 EGFR-mutant lung adenocarcinoma …
Gefitinib in the treatment of Asian patients with exon 19 EGFR-mutant lung adenocarcinoma …
Erlotinib versus gefitinib for brain metastases in Asian patients with exon 19 EGFR-mutant lung adenocarcinoma: a retrospective, multicenter study.
Y Jiang, J Zhang, J Huang, B Xu, N Li… - BMC Pulmonary …, 2018 - europepmc.org
Background The purpose of this study was to compare clinical outcomes of Erlotinib versus
Gefitinib in the treatment of Asian patients with exon 19 EGFR-mutant lung adenocarcinoma …
Gefitinib in the treatment of Asian patients with exon 19 EGFR-mutant lung adenocarcinoma …